Abstract
The pathologic alterations of the pancreas in type 2 diabetes are more discrete than in type 1 diabetes. It has therefore been claimed, even quite recently, that the morphology of the islets is normal in this maturity form of the disease. However, there are some changes which are typical of type 2 diabetes and demonstrable in most, although not all cases. The most constant of these changes is probably deposition of amyloid in the islets of Langerhans.
Chapter PDF
References
Opie EL (1900) On relation of chronic interstitial pancreatitis to the islets of Langerhans and to diabetes mellitus. J Exp Med 5: 397–428
Weichselbaum A, Stangl E (1901) Zur Kenntnis der feineren Veranderungen des Pankreas bei Diabetes mellitus. Wien Klin Wochenschr 14: 968–972
Gellerstedt N (1938) Die elektive, insulare (Para-) Amyloidose der Bauchspeicheldriise. Beitr Path Anat 101: 1–13
Ahronheim JH (1943) The nature of the hyaline material in the pancreatic islands in diabetes mellitus. Am J Path 19: 873–882
Arey JB (1943) Nature of the hyaline changes in islands of Langerhans in diabetes mellitus. Arch Pathol 36: 32–38
Ehrlich JC, Ratner IM (1961) Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Pathol 38: 49–59
Glenner GG (1980) Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med 302: 1283–1292 and 1333–1343
Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD (1974) Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22: 1141–1158
Westermark P, Johnson KH (1988) The polypeptide hormone-derived amyloid forms: non-specific alterations or signs of abnormal peptide-processing? APMIS 96: 475–483
Westermark P, Grimelius L (1973) The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 81: 291–300
Westermark P (1977) Amyloid of human islets of Langerhans. II. Electron microscopic analysis of isolated amyloid. Virchows Arch Path Anat 373: 161–166
Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch Path Anat 359: 1–18
Westermark P (1972) Quantitative studies of amyloid in the islets of Langerhans. Upsala J Med Sci 77: 91–94
Clark A, Holman RR, Matthews DR, Hockaday TDR, Turner RC (1984) Non-uniform distribution of amyloid in the pancreas of “maturity-onset” diabetic patients. Diabetologia 27: 527–528
Lazarus SS, Volk BW (1962) The pancreas in human and experimental diabetes. Grune and Stratton, New York
Bell ET (1959) Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 35: 801–805
Ludwig G, Heitner H (1967) Zur Häufigkeit der Inselamyloidose des Pankreas beim Diabetes mellitus. Zschr Inn Med 22: 814–818
Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417–421
Westermark P, Cornwell GG III (1986) Varied composition and nature of senile localized amyloid: implications for varied mechanisms of pathogenesis. In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D (eds) Amyloidosis. Plenum Press, New York, pp 659–668
Westermark P, Grimelius L, Polak JM, Larsson L-I, van Noorden S, Wilander E, Pearse AGE (1977) Amyloid in polypeptide hormone-producing tumors. Lab Invest 37: 212–215
Berns AW, Owens CT, Blumenthal HT (1964) A histo-and immunopathologie study of the vessels and islets of Langerhans of the pancreas in diabetes mellitus. J Gerontol 19: 179–189
Lacy PE (1964) Pancreatic beta cell. In: Aetiology of diabetes and its complications. Ciba Foundation Colloquia on Endocrinology. Little, Brown, Boston, p 75
Westermark P (1974) On the nature of the amyloid in human islets of Langerhans. Histochemistry 38: 27–33
Westermark P, Wilander E (1983) Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 24: 342–346
Westermark P (1975) Amyloid of medullary carcinoma of the thyroid: partial characterization. Upsala J Med Sci 80: 88–92
Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827–831
Westermark P, Wernstedt C, Wilander E, Hayden DW, O’Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a novel neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881–3885
Westermark P, Wernstedt C, O’Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414–417
Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628–8632
Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, Gilbey SG, Watkins PJ (1988) Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 31: 158–161
Johnson KH, Stevens JB (1973) Light and electron microscopic studies of islet amyloid in diabetic cats. Diabetes 22: 81–90
Johnson KH, Hayden DW, O’Brien TD, Westermark P (1986) Spontaneous diabetes mellitus-islet amyloid complex in adult cats. Am J Pathol 125: 416–419
Howard CF (1978) Insular amyloidosis and diabetes mellitus in Macaca nigra. Diabetes 27: 357–364
Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887–892
Johnson KH, O’Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, Westermark P (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase antiperoxidase ( PAP) and protein A-gold techniques. Am J Pathol 130: 1–8
Westermark P, Engsträm U, Westermark GT, Wilander E, Johnson KH (1988) A limited segment of islet amyloid polypeptide (IAPP) is related to amyloid fibril formation in type 2 diabetes. (Submitted for publication)
Westermark P, Johnson KH (1988) The pathogenesis of maturity onset diabetes mellitus: Is there a link to islet amyloid polypeptide? Bio Essays 9: 30–33
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Westermark, P. (1989). Islet Amyloid and Type 2 Diabetes. In: Creutzfeldt, W., Lefèbvre, P.J. (eds) Diabetes Mellitus: Pathophysiology and Therapy. Bayer AG Centenary Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74255-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-74255-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50506-8
Online ISBN: 978-3-642-74255-2
eBook Packages: Springer Book Archive